Kamal Doghmi Selected Research

Kamal Doghmi Research Topics

2	Posterior Leukoencephalopathy Syndrome 05/2022 - 06/2013
2	Hodgkin Disease (Hodgkin's Disease) 04/2022 - 09/2011
2	Lymphoma (Lymphomas) 06/2021 - 04/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 12/2017
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2016 - 07/2013
2	Hairy Cell Leukemia 05/2006 - 11/2003
1	Brain Diseases (Brain Disorder) 05/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022
1	Thrombosis (Thrombus) 02/2022
1	Neoplasms (Cancer) 02/2022
1	Hepatitis B 06/2021
1	COVID-19 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Splenomegaly 12/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Immunoglobulin Light-chain Amyloidosis 01/2017
1	Cytopenia 08/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2015
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 07/2013
1	Piebaldism (Partial Albinism) 07/2013
1	Reinfection 07/2013
1	Heart Diseases (Heart Disease) 05/2006
1	Neutropenia 05/2006

2	Rituximab (Mabthera)FDA Link 05/2022 - 05/2006
2	Biological ProductsIBA 12/2017 - 07/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 06/2013
2	purineIBA 05/2006 - 11/2003
1	Prednisone (Sone)FDA LinkGeneric 05/2022
1	R-CHOP protocolIBA 05/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2022
1	Vincristine (Oncovin)FDA LinkGeneric 05/2022
1	Antimitotic AgentsIBA 04/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2022
1	Antiviral Agents (Antivirals)IBA 06/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021
1	Sickle HemoglobinIBA 12/2017
1	Azacitidine (5 Azacytidine)FDA Link 12/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	hemoglobin P (Hb P)IBA 08/2016
1	Imatinib Mesylate (Gleevec)FDA Link 03/2015
1	SilverIBA 07/2013
1	InterferonsIBA 05/2006

5	Drug Therapy (Chemotherapy) 05/2022 - 09/2011
1	VAP-cyclo protocol 05/2022
1	Splenectomy 06/2021
1	Tracheotomy 01/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020
1	Cord Blood Stem Cell Transplantation 06/2013
1	Therapeutics 11/2003